Free Trial

NeuroOne Medical Technologies (NMTC) SEC Filings & 10K Form

NeuroOne Medical Technologies logo
$1.15 +0.03 (+2.68%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.16 +0.01 (+0.43%)
As of 02/21/2025 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NeuroOne Medical Technologies SEC Filings

DateFilerForm TypeView
02/20/2025
3:47 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
11:18 AM
BUCKMAN PAUL (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
11:00 AM
MATHIESEN JEFFREY S (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
11:06 AM
Andrle Edward (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:15 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:11 PM
MANCHESTER MANAGEMENT CO LLC (Filed by)
NeuroOne Medical Technologies (Subject)
Form SCHEDULE 13G/A
02/12/2025
7:30 AM
NeuroOne Medical Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/12/2025
7:15 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:05 PM
NeuroOne Medical Technologies (Filer)
Form DEFA14A
02/04/2025
12:48 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
12:33 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
12:41 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:15 PM
NeuroOne Medical Technologies (Filer)
Form DEF 14A
01/21/2025
3:25 PM
NeuroOne Medical Technologies (Filer)
Form ARS
01/14/2025
7:30 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:51 PM
NeuroOne Medical Technologies (Filer)
Form PRER14A
01/10/2025
4:04 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:41 PM
NeuroOne Medical Technologies (Filer)
Form PRE 14A
01/10/2025
8:00 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
2:41 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:39 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:40 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:40 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
7:29 AM
NeuroOne Medical Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/03/2024
3:50 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:57 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:04 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:42 AM
LYTTON LAURENCE W (Filed by)
NeuroOne Medical Technologies (Subject)
Form SC 13G/A
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
NeuroOne Medical Technologies (Subject)
Form SCHEDULE 13G/A
11/01/2024
4:06 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:14 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:23 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:05 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
10:32 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
10:44 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
10:22 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM
NeuroOne Medical Technologies (Filer)
Form EFFECT
09/13/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
8:03 AM
NeuroOne Medical Technologies (Filer)
Form S-3/A
09/04/2024
10:36 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
10:43 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon’s “New Gold” (Ad)

MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.

I reveal all of the details here.
09/04/2024
10:26 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2024
11:15 PM
NeuroOne Medical Technologies (Filer)
Form EFFECT
08/16/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 424B5
08/16/2024
9:39 AM
NeuroOne Medical Technologies (Filer)
Form D
Notice of Exempt Offering of Securities 
08/14/2024
3:34 PM
NeuroOne Medical Technologies (Filer)
Form S-3/A
08/14/2024
7:59 AM
NeuroOne Medical Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
1:31 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
1:38 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
1:16 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:49 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
10:00 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
10:09 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
10:21 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:15 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
2:34 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:49 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:39 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:48 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
10:24 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
10:19 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:16 PM
NeuroOne Medical Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:10 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:57 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
8:06 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:49 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
9:09 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
9:21 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
8:53 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:52 AM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:45 AM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
10:34 AM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
8:20 AM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:30 PM
NeuroOne Medical Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
1:01 PM
NeuroOne Medical Technologies (Issuer)
Rosa David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
1:10 PM
Mertens Steve (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
12:50 PM
Christianson Mark (Reporting)
NeuroOne Medical Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NMTC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners